Intimate partner violence is notoriously underreported and correctly diagnosed at hospitals only around a quarter of the time, but a new method provides a more realistic picture of which groups of women are most affected, even when their cases go unrecorded.
A clinical trial led by Weill Cornell Medicine investigators showed that a nasal spray that patients administer at home, without a physician, successfully and safely treated recurrent episodes of a condition that causes rapid abnormal heart rhythms.
Researchers at Weill Cornell Medicine and NewYork-Presbyterian found that a self-guided cognitive behavioral therapy app significantly reduced anxiety in young adults struggling with mental health challenges.
The transition to menopause is marked by a progressively higher density of estrogen receptors on brain cells, a measure that remains elevated in women up to their mid-60s, according to a new brain imaging study.
An American Heart Association Presidential Advisory, co-authored by Mario Herrero, professor in global development, calls for building on existing research and implementing cross-sector approaches to Food Is Medicine.
Ashley Nelson, assistant professor of immunology research in the Department of Pediatrics at Weill Cornell Medicine, has received a 2023 Hartwell Individual Biomedical Research Award from The Hartwell Foundation.
An artificial intelligence-powered method for detecting tumor DNA in blood has the potential to improve cancer care with the very early detection of recurrence and close monitoring of tumor response during therapy.
Weill Cornell Medicine and colleagues in Tanzania are fostering a new generation of M.D./Ph.D. researchers, with implications for improved health care outcomes worldwide.
The FDA has approved tirzepatide – which will be sold under the brand name Zepbound – to treat overweight and obesity. It’s the latest entrant into a field of powerful new drugs that includes Ozempic and Wegovy.
